INSMED Inc (INSM) stock forecast and price target
Price $121.16 · data as of November 13, 2026
12-month price target
Average target$194.18
Upside / downside+60.3%
Analysts22
ConsensusStrong buy
Low $158.00Average $194.18High $243.00
Gold marker: average target · white marker: today’s price ($121.16)
Analyst ratings
Strong buy 5Buy 18Hold 1Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.67 | +74.0% | $1.9B |
| Next fiscal year ends December 31, 2027 | $0.66 | +139.4% | $3.0B |
| Next quarter ends December 31, 2026 | $-0.34 | +77.8% | $605M |
| Quarter after ends March 31, 2027 | $-0.28 | +63.2% | $626M |
Consensus of the analysts covering INSMED, updated daily. In the last 30 days 3 estimates were raised and 9 lowered.
Frequently asked questions
What is the INSMED stock price target?
The average 12-month target from 22 analysts is $194.18, 60.3% above the current price of $121.16 Targets range from $158.00 to $243.00.
Is INSMED a buy according to analysts?
The consensus rating is “Strong buy” (5 strong buy, 18 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is INSMED expected to earn?
Analysts expect EPS of $-1.67 for the fiscal year ending December 31, 2026 and $0.66 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.